Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Journal of Cancer

Showing results (221-230 of 5,561) with videos related to

Pageof 557
Sort By:
Journal of Cancer|September 3, 2021
Priority of PET-CT vs CT Thorax for EBUS-TBNA 22G vs 19G: Mesothorax LymphadenopathyPaul Zarogoulidis, Haidong Huang, Zhenli Hu, et al.
Journal of Cancer|September 3, 2021
Research progress, challenges and perspectives on PNPLA3 and its variants in Liver DiseasesHongjiao Xiang, Zecheng Wu, Junmin Wang, et al.
Journal of Cancer|September 3, 2021
INHBA is a novel mediator regulating cellular senescence and immune evasion in colorectal cancerShuai Chen, Yu Gong, Yu Shen, et al.
Journal of Cancer|September 3, 2021
Use of bioinformatic database analysis and specimen verification to identify novel biomarkers predicting gastric cancer metastasisWeimin Wang, Ke Min, Gaoyang Chen, et al.
Journal of Cancer|May 6, 2020
Development and Validation of an Individualized Nomogram for Predicting Survival in Patients with Esophageal Carcinoma after ResectionFeng Du, Zhiwei Sun, Jun Jia, et al.
Journal of Cancer|May 6, 2020
Plasma exo-hsa_circRNA_0056616: A potential biomarker for lymph node metastasis in lung adenocarcinomaFei He, Xuejing Zhong, Zheng Lin, et al.
Journal of Cancer|May 6, 2020
HDAC Inhibitor, CG-745, Enhances the Anti-Cancer Effect of Anti-PD-1 Immune Checkpoint Inhibitor by Modulation of the Immune MicroenvironmentYoung-Dae Kim, Sang-Min Park, Hae Chan Ha, et al.
Journal of Cancer|May 6, 2020
The Expression of Perilipin Family Proteins can be used as Diagnostic Markers of Liposarcoma and to Differentiate SubtypesQiaochu Zhang, Pengpeng Zhang, Bingcheng Li, et al.
Journal of Cancer|May 6, 2020
Outcomes of Adjuvant Oral versus Intravenous Fluoropyrimidines for High-Risk Stage II or Stage III Colon Adenocarcinoma: A Propensity Score-Matched, Nationwide, Population-Based Cohort StudyJiaqiang Zhang, Yu-Chun Yen, Lei Qin, et al.
Journal of Cancer|May 6, 2020
High expression of folate cycle enzyme MTHFD1L correlates with poor prognosis and increased proliferation and migration in colorectal cancerZhongyun He, Xia Wang, Huizhong Zhang, et al.
Pageof 557

Showing results (221-230 of 5,561) with videos related to

Sort By:
Pageof 557
Journal of Cancer|September 3, 2021
Priority of PET-CT vs CT Thorax for EBUS-TBNA 22G vs 19G: Mesothorax LymphadenopathyPaul Zarogoulidis, Haidong Huang, Zhenli Hu, et al.
Journal of Cancer|September 3, 2021
Research progress, challenges and perspectives on PNPLA3 and its variants in Liver DiseasesHongjiao Xiang, Zecheng Wu, Junmin Wang, et al.
Journal of Cancer|September 3, 2021
INHBA is a novel mediator regulating cellular senescence and immune evasion in colorectal cancerShuai Chen, Yu Gong, Yu Shen, et al.
Journal of Cancer|September 3, 2021
Use of bioinformatic database analysis and specimen verification to identify novel biomarkers predicting gastric cancer metastasisWeimin Wang, Ke Min, Gaoyang Chen, et al.
Journal of Cancer|May 6, 2020
Development and Validation of an Individualized Nomogram for Predicting Survival in Patients with Esophageal Carcinoma after ResectionFeng Du, Zhiwei Sun, Jun Jia, et al.
Journal of Cancer|May 6, 2020
Plasma exo-hsa_circRNA_0056616: A potential biomarker for lymph node metastasis in lung adenocarcinomaFei He, Xuejing Zhong, Zheng Lin, et al.
Journal of Cancer|May 6, 2020
HDAC Inhibitor, CG-745, Enhances the Anti-Cancer Effect of Anti-PD-1 Immune Checkpoint Inhibitor by Modulation of the Immune MicroenvironmentYoung-Dae Kim, Sang-Min Park, Hae Chan Ha, et al.
Journal of Cancer|May 6, 2020
The Expression of Perilipin Family Proteins can be used as Diagnostic Markers of Liposarcoma and to Differentiate SubtypesQiaochu Zhang, Pengpeng Zhang, Bingcheng Li, et al.
Journal of Cancer|May 6, 2020
Outcomes of Adjuvant Oral versus Intravenous Fluoropyrimidines for High-Risk Stage II or Stage III Colon Adenocarcinoma: A Propensity Score-Matched, Nationwide, Population-Based Cohort StudyJiaqiang Zhang, Yu-Chun Yen, Lei Qin, et al.
Journal of Cancer|May 6, 2020
High expression of folate cycle enzyme MTHFD1L correlates with poor prognosis and increased proliferation and migration in colorectal cancerZhongyun He, Xia Wang, Huizhong Zhang, et al.
Pageof 557